Data Mining for Chinese Materia Medica and Pharmacological Research

Chinese materia medica (CMM) is becoming increasingly important in modern health care, with the potential for new or improved clinical protocols and reduction in treatment costs. Conventional approaches to drug discovery are based on knowledge of biological systems and screen phenotypes in the context of a whole organism. It will be valuable to identify the CMM that would induce certain biological responses (such as angiogenesis). The authors have developed a database that they plan to commercialize that contains traditional knowledge of Chinese medicine and pharmacology along with their own experimental data from controlled scientific observations by using the zebrafish as a model of CMM-induced pathology. The database is visualized and functions via the World Wide Web by subscription or license. The authors have also written software for personal digital assistant (PDA) devices that supports multiple users performing screening experiments worldwide. This provides a platform for the study of CMM, and data mining of this resource will help evaluate CMM in the context of experimental observations of biological aberrations. (Journal of Biomolecular Screening 2008:390-395)

[1]  Stuart L Schreiber,et al.  Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation , 2004, Nature Biotechnology.

[2]  G. Serbedzija,et al.  Zebrafish angiogenesis: A new model for drug screening , 2004, Angiogenesis.

[3]  Yang Yifan,et al.  Chinese Herbal Medicines: Comparisons and Characteristics , 2001 .

[4]  Zhaohui Wu,et al.  Knowledge discovery in traditional Chinese medicine: State of the art and perspectives , 2006, Artif. Intell. Medicine.

[5]  B. Weinstein,et al.  Angiogenic network formation in the developing vertebrate trunk , 2003, Development.

[6]  Padhraic Smyth,et al.  From Data Mining to Knowledge Discovery in Databases , 1996, AI Mag..

[7]  U. Langheinrich,et al.  Zebrafish: a new model on the pharmaceutical catwalk. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[8]  Russell Hughes,et al.  Current methods for assaying angiogenesis in vitro and in vivo , 2004, International journal of experimental pathology.

[9]  Tingjun Hou,et al.  A 3D Structure Database of Components from Chinese Traditional Medicinal Herbs , 2002, J. Chem. Inf. Comput. Sci..

[10]  L. Zon,et al.  In vivo drug discovery in the zebrafish , 2005, Nature Reviews Drug Discovery.

[11]  F. Koehn,et al.  The evolving role of natural products in drug discovery , 2005, Nature Reviews Drug Discovery.

[12]  Xu Hao,et al.  The integration of traditional Chinese medicine and Western medicine , 2003, European Review.

[13]  Min He,et al.  Traditional Chinese Medicine Database and Application on the Web , 2001, J. Chem. Inf. Comput. Sci..

[14]  Y. Z. Chen,et al.  Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation , 2006, British journal of pharmacology.

[15]  David B. Searls,et al.  Data integration: challenges for drug discovery , 2005, Nature Reviews Drug Discovery.

[16]  I. Whyte,et al.  Development of a Chinese Herbal Medicine Toxicology Database* , 2002, Journal of toxicology. Clinical toxicology.

[17]  Xueguo Chen,et al.  Strategy for analysis and screening of bioactive compounds in traditional Chinese medicines. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.